Exosomes Market Overview
Exosomes Market was valued at USD 191.1 Million in 2024 and is projected to grow at a CAGR of 4.40% to reach USD 3328.2 Million by 2034.
Exosomes are cell-derived and the minor type of extracellular vesicles of endosomal origin, enveloped with the lipid bilayer. Exosomes play an essential role in cell biology and, thus, represent a novel model of cell communication.
A wide variety of applications of exosomes and technological innovation in exosome isolation have provided lucrative opportunities for market growth. The rising prevalence of cancer diseases and government spending on exosome research is further expected to favor exosome market growth in coming years.
For More Report Details, Download Free Sample PDF
Exosomes Market Drivers & Restraints
Rising prevalence of cancer diseases due to unhealthy lifestyle, poor nutrition food, lack of exercise has given positive impact on Exosomes market growth. Wide variety of applications in various diseases has favored market growth.
According to PMC (PubMed Central), in 2018, exosome-based drug delivery strategies in clinical and preclinical showed dramatically decrease in development of cancer and function as cell free vaccines by providing alternative strategies for exosome-based anticancer therapies in cancer treatment which, in turn is likely to provide lucrative opportunities in Exosomes market growth.
- For instance, in 2019, according to CDC (Centers for Disease Control and Prevention), around 1,752,735 new cancer cases were reported and 599,589 people were died of cancer in United States. Thus, growing prevalence of cancer diseases has foster the demand for Exosomes market growth.
Restrains:
However, several challenges to face by scientist in exosome manufacturing, research & development activity due to mistakes done by researchers has restrains market growth. Lack of gold standard procedures for exosome production has hampered Exosomes market growth.
Exosomes Market Segmentations & Regional Insights
Exosomes Market is segmented based on Product, Workflow, Application, End-Users and Region.
Product Insight
On the basis of Product, Exosomes Market is segmented into Instruments, Kits & Reagents, Services. Kits & Reagents product segment is expected to dominate the target market growth. Kits & Reagents are further divided into isolation, purification, antibodies, quantitation kits & reagents which has driven product segment.
Workflow Insights
On the basis of Workflow, Exosomes Market is segmented into Downstream Analysis, Isolation Methods. Downstream Analysis workflow segment is expected to dominate the target market growth due to advancement in product for downstream analysis and presence of major key players in offering various technologically innovative products in analysis.
Application Insights
On the basis of Application, Exosomes Market is segmented into Infectious Diseases, Cardiovascular Diseases, Neurodegenerative Diseases, Cancer, and Others. Cancer application segment is expected to dominate the target market growth due to growing demand of exosomes research in lung cancer management.
End-Users Insights
On the basis of End-Users, Exosomes Market is segmented into Hospitals, Academic & Research Institutes, Diagnostic Centers, Pharmaceutical Companies, and Others. Academic & Research Institutes segment is expected to dominate the target market growth due to growing demand for exosome research from past few years due to potential applications in diagnosis of disease.
Regional Insights:
On region the Exosomes Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period. Moreover, rising prevalence of cancer disease, unhealthy diet, sedentary lifestyle, high disposable income, growing research & development activities in exosomes, government initiative and funding in exosome research, technological advancement and well advanced research institutes, is anticipated to increase demand for Exosomes in the region.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Million & CAGR from 2024 to 2034 |
|
Market Segmentation |
By Product - Instruments, Kits & Reagents, Services By Workflow - Downstream Analysis, Isolation Methods By Application - Infectious Diseases, Cardiovascular Diseases, Neurodegenerative Diseases, Cancer, and Others By End-Users - Hospitals, Academic & Research Institutes, Diagnostic Centers, Pharmaceutical Companies, and Others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Exosomes Market report based on Product, Workflow, Application, End-Users and Region.
Exosomes Market, By Product:
- Instruments
- Kits & Reagents
- Services
Exosomes Market, By Workflow:
- Downstream Analysis
- RNA analysis with PCR and NGS
- Protein analysis using blotting & ELISA
- Cell surface marker analysis using flow cytometry
- Proteomic analysis using mass spectroscopy
- Others
- Isolation Methods
- Precipitation
- Ultracentrifugation
- Filtration
- Immunocapture on beads
- Others
Exosomes Market, By Application:
- Infectious Diseases
- Cardiovascular Diseases
- Neurodegenerative Diseases
- Cancer
- Others
Exosomes Market, By End-Users:
- Hospitals
- Academic & Research Institutes
- Diagnostic Centers
- Pharmaceutical Companies
- Others
Exosomes Market, By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Exosomes Market Competitive Landscape & Key Players
The key players operating the Exosomes Market includes, Hologic Inc., Bio-Techne Corp., Danaher Corp., Lonza, Fujifilm Holdings Corp., Thermo Fisher Scientific Inc., QIAGEN, RoosterBio Inc., Miltenyi Biotec, Abcam plc., and others.
Exosomes Market Recent News
Recent Development:
- In February 2021, Evox Therapeutics has set in developing treatments for inborn errors of metabolism. The company has raised around $95.4 million from GV and OrbiMed to advance pipeline of Exosome-based treatments in clinic.
Exosomes Market Company Profile
- Hologic Inc.
- Bio-Techne Corp.
- Danaher Corp.
- Lonza
- Fujifilm Holdings Corp.
- Thermo Fisher Scientific Inc.
- QIAGEN
- RoosterBio Inc.
- Miltenyi Biotec
- Abcam plc
Exosomes Market Highlights
FAQs
The Exosomes Market is segmented into Product, Workflow, Application, End-Users and Region.
Exosomes Market is driven by factors like growing prevalence of cancer diseases.
By region, the Exosomes market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.
The key players operating the Exosomes Market includes, Hologic Inc., Bio-Techne Corp., Danaher Corp., Lonza, Fujifilm Holdings Corp., Thermo Fisher Scientific Inc., QIAGEN, RoosterBio Inc., Miltenyi Biotec, Abcam plc., and others.
Exosomes Market accounted for US$ 112.25 Million in 2022 and is estimated to be US$ 1,955.3 Million by 2032 and is anticipated to register a CAGR of 31.1%.